Rybelsus vs. Jardiance

See how Rybelsus and Jardiance compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Rybelsus is an oral GLP-1 receptor agonist that lowers blood sugar and cuts cardiovascular risk, taken as a daily pill on an empty stomach.

  • Jardiance is an oral SGLT2 inhibitor with a simpler once-daily dose that also protects the heart and kidneys, including in heart failure.

  • Both treat type 2 diabetes but work through completely different mechanisms, so a doctor may combine them rather than choose one over the other.

Rybelsus vs. Jardiance Drug Summary

Rybelsus

Rybelsus (semaglutide) is an oral GLP-1 receptor agonist used to control blood sugar in type 2 diabetes and to lower the risk of major cardiovascular events in patients with established heart disease. It is taken as a tablet once a day on an empty stomach, starting at 3 mg and increasing over about two months to a 14 mg maintenance dose.

Jardiance

Jardiance (empagliflozin) is an oral SGLT2 inhibitor used to control blood sugar in type 2 diabetes and to reduce cardiovascular death, heart failure hospitalization, and kidney disease progression. It is taken as a single daily tablet at 10 mg, with an option to increase to 25 mg if more blood sugar control is needed.

Rybelsus vs. Jardiance Side Effects

Rybelsus

Most common
nausea (up to 20%)
abdominal pain (up to 11%)
diarrhea (up to 10%)
decreased appetite (up to 9%)

Jardiance

Most common
hypoglycemia (up to 41.3% w/ insulin/SU)
volume depletion related reactions (up to 11.4%)
urinary tract infection (up to 9.3%)
increased urination (1%-10%)

Rybelsus vs. Jardiance Dosage

Rybelsus

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 3 mg once daily Days 1-30
Maximum dose 14 mg once daily Day 61 onward
Dose changes 2 increases Every 30 days

Jardiance

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily At the start
Maximum dose 25 mg once daily If needed
Dose changes 1 increase As tolerated

Rybelsus vs. Jardiance Indications

Rybelsus

Rybelsus is FDA-approved to improve blood sugar control in adults with type 2 diabetes and to reduce the risk of heart attack, stroke, or cardiovascular death in those with existing heart disease. It is not approved for type 1 diabetes or for chronic weight management, though some doctors prescribe it off-label for weight loss.

  • Blood sugar control in type 2 diabetes

  • Cardiovascular risk reduction with known heart disease

  • Off-label: weight loss in people without diabetes

Jardiance

Jardiance is FDA-approved for blood sugar control in adults and children 10 and older with type 2 diabetes, and it carries broader heart and kidney approvals than Rybelsus. It reduces cardiovascular death risk, heart failure hospitalization regardless of ejection fraction, and the progression of chronic kidney disease.

  • Blood sugar control in type 2 diabetes, including pediatric patients

  • Cardiovascular death risk reduction with heart disease

  • Heart failure hospitalization and death risk reduction

Rybelsus vs. Jardiance Pros and Cons

Rybelsus

Rybelsus offers the added benefit of appetite reduction and meaningful weight loss alongside blood sugar control, plus proven cardiovascular protection. It requires a strict routine of taking it on an empty stomach with a small amount of water and waiting 30 minutes before eating.

Pros

  • Often leads to noticeable weight loss as a side benefit

  • First and only oral GLP-1 approved for type 2 diabetes

  • Reduces cardiovascular event risk in heart disease patients

Cons

  • Typically costs $998 to $1,029 per month without insurance

  • GI side effects like nausea and vomiting are common

  • Carries a boxed warning for thyroid C-cell tumor risk

  • Must be taken on an empty stomach with strict timing

Jardiance

Jardiance has a simpler dosing routine with no titration and no food or timing restrictions, and its approvals extend into heart failure and chronic kidney disease care. Its main risks involve genital infections and dehydration-related drops in blood pressure rather than digestive side effects.

Pros

  • No titration schedule, effective from the first dose

  • Typically costs $350 to $620 per month without insurance

  • Approved for heart failure regardless of ejection fraction

Cons

  • Raises risk of genital yeast and urinary tract infections

  • Can cause diabetic ketoacidosis even with normal blood sugar

  • Risk of dehydration and low blood pressure, especially in older adults

  • Not associated with meaningful weight loss

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.